Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms

Cancer therapies targeting epidermal growth factor receptor (EGFR), such as small-molecule kinase inhibitors and monoclonal antibodies, have been developed as standard therapies for several cancers, such as non-small cell lung cancer, colorectal cancer, pancreatic cancer, breast cancer, and squamous...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaoka, Toshimitsu, Ohba, Motoi, Ohmori, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713388/
https://www.ncbi.nlm.nih.gov/pubmed/29140271
http://dx.doi.org/10.3390/ijms18112420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713388/
https://www.ncbi.nlm.nih.gov/pubmed/29140271
http://dx.doi.org/10.3390/ijms18112420

Ejemplares similares